An international audit of the management of dyslipidaemia and hypertension in patients with rheumatoid arthritis-results from 19 countries.
Silvia RollefstadEirik IkdahlGrunde WibetoeJoe SextonCynthia S CrowsonPiet van RielGeorge D KitasIan M GrahamSolbritt Rantapää DahlqvistGeorge KarpouzasElena MyasoedovaMiguel A Gonzalez-GayPetros P SfikakisMaria G TektonidouArgyro LazariniDimitrios VassilopoulosBindee KuriyaCarol A HitchonMaria Simona StoenoiuPatrick DurezVirginia Pascual-RamosDionicio Angel Galarza-DelgadoPompilio FaggianoDurga Prasanna MisraAndrew BorgRong MuErkin M MirrakhimovDiane GhetaSvetlana MyasoedovaLev KrouglyTatiana PopkovaAlena TuchyňováMichal TomcikMichal VrablikJiri LastuvkaPavel HorákHelena MedkováAnne Grete SembPublished in: European heart journal. Cardiovascular pharmacotherapy (2021)
We revealed considerable geographical differences in estimated CVD risk and preventive treatment. Low goal attainment for LLT was observed, and only half the patients obtained BP goal. Despite a high focus on the increased CVD risk in RA patients over the last decade, there is still substantial potential for improvement in CVD preventive measures.